Skip to main content
Premium Trial:

Request an Annual Quote

Aclara Licenses eTag System to Tokyo Medical Science Institute

NEW YORK (GenomeWeb News) Oct. 1 - Aclara Biosciences of Mountain View, Calif., has signed an agreement to provide Rinshoken, the Tokyo Metropolitan Institute of Medical Science, with access to its eTag Assay system, the company said today.


TMIMS researcher Futoshi Shibasaki will use the system to develop multiplexed assays for hypoxia-inducible factors in cells and tissues, which occur in heart attack, stroke, and other cerebrovascular disorders, according to Aclara. Shibasaki's laboratory studies the way gene expression is modulated by hypoxic responsive factors, in an effort to discover diagnostic and therapeutic targets in this area.


The license also includes access to the reagent products, the software, and support for the system.

"We would like to analyze specific proteins for their dependence on HIFs under several experimental conditions that mimic disease situations, Futoshi Shibasaki, director of the Molecular Cell Physiology Laboratory at TMIMS, said in a statement. "Moreover, these types of assays could be valuable for diagnosis and patient stratification in cancer."


This is Aclara's first deal with a Japanese research organization.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.